LOS ANGELES, April 27, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Clubhouse Media Group, Inc. (OTCMKTS:CMGR) (“Clubhouse Media” or the...
MONTREAL, April 27, 2021 (GLOBE NEWSWIRE) -- The Board of Directors of Terranueva Corporation (CSE: TEQ) ("Terranueva" or the "Company")...
Generex receives $2 million payment from Chinese partners to provide research results, data, and necessary documents to support an IND...
PITTSBURGH, April 27, 2021 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase”), a biotechnology company accelerating the genetic revolution...
Six months of positive cash flow from operations. Turnaround complete and focused on growth and optimization.PORTLAND, Ore., April 27, 2021...
SAN DIEGO, April 27, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced that data...
CHICAGO, April 27, 2021 (GLOBE NEWSWIRE) -- Wesana Health Inc. (“Wesana” or the “Company”), an emerging life sciences company focused...
Presentations highlight the pathogenic role of the CD6-ALCAM pathway, the immunologic impact of modulating this pathway with itolizumab, and pharmacodynamic...
CAMBRIDGE, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery...
Strengthens therapeutic development programs with key hires in Pharmacology and ToxicologyVANCOUVER, British Columbia, April 27, 2021 (GLOBE NEWSWIRE) -- Bright...
Virtual KOL Event is scheduled for Today, April 27th @ 10:30 AM ETAUSTIN, Texas, April 27, 2021 (GLOBE NEWSWIRE) --...
Pyxis Oncology to host webcast with Key Opinion Leaders (KOLs) on April 27, 2021 at 1:00pm ETCAMBRIDGE, Mass., April 27,...
FINTEPLA is approved in the U.S. and European Union as an add-on therapy for the treatment of seizures associated with...
Dr. Curley brings extensive pharmaceutical industry experience in product development, commercialization and operations as VistaGen advances late-stage development of its...
Study concludes the utilization of T2 Magnetic Resonance (T2MR®) provides faster time to detection, faster time to targeted therapy, and...
Additional case studies support the broad potential of AC5® Advanced Wound System in chronic and non-healing woundsFRAMINGHAM, Mass., April 27,...
CLEVELAND, April 27, 2021 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization...
NOVA LIMA, Brazil and MINAS GERAIS, Brazil, April 27, 2021 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA), the...
BEDMINSTER, N.J., April 27, 2021 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on...
Phase 3 Pivotal Cardigan II study exceeds 50% enrollment- - -Topline results for Phase 3 Pivotal Cardigan I and Cardigan...